NuCana Plc (NCNA)
3.70
+0.10
(+2.78%)
USD |
NASDAQ |
Jan 02, 11:08
NuCana Free Cash Flow: -18.19M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -14.30M |
| Autolus Therapeutics Plc | -306.93M |
| Mereo BioPharma Group Plc | -33.02M |
| Bicycle Therapeutics Plc | -242.07M |
| Adaptimmune Therapeutics Plc | -193.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.586M |
| Cash from Investing (Quarterly) | -0.0656M |
| Cash from Financing (Quarterly) | 20.55M |
| Free Cash Flow Per Share (Quarterly) | 0.4112 |
| Free Cash Flow to Equity (Quarterly) | 1.548M |
| Free Cash Flow to Firm (Quarterly) | 1.520M |
| Free Cash Flow Yield | -410.6% |